FIELD: medicine. SUBSTANCE: this method prescribes using heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro as nootropic drug. Novel nootropic composition includes about 0.95 to 1.05 g/l heptapeptide as active compound and 0.95 to 1.05 g/l of Nipagin as conservant, water being remainder. EFFECT: higher effectiveness when administered nasally in small doses (droplets) and greater simplicity. 2 cl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR TREATING ISCHEMIC INSULT AND METHOD FOR THERAPY | 2002 |
|
RU2251429C2 |
METHOD FOR TREATMENT OF NERVOUS SYSTEM DISORDER IN CHILDREN OF YOUNGEST AGE AND PHARMACEUTICAL COMPOSITION | 2003 |
|
RU2241487C1 |
AGENT FOR PROPHYLAXIS AND TREATMENT OF GASTROENTERIC TRACT ULCERS, METHOD OF TREATMENT AND METHOD OF PROPHYLAXIS OF GASTROENTERIC TRACT ULCERS | 2001 |
|
RU2191593C1 |
HEXAPEPTIDE ELICITING MEMORY STIMULATING ACTIVITY | 1998 |
|
RU2131743C1 |
METHOD OF TREATMENT OF HUNTINGTON'S CHOREA | 1996 |
|
RU2136309C1 |
METHOD FOR TREATING THE CASES OF ISCHEMIC INSULT | 1997 |
|
RU2124365C1 |
HEPTAPEPTIDE ELICITING ANALGETIC ACTIVITY COMBINING WITH THERMOREGULATORY AND/OR VASOMOTOR ACTIVITY AND/OR WITH EFFECT ON BEHAVIOR RESPONSE OF TESTING ORGANISM AND METHOD OF ALTERNATION OF PHYSIOLOGICAL ACTIVITY OF DERMORPHINE | 1997 |
|
RU2134121C1 |
ANTI-THROMBOSIS, ANTICOAGULANT, FIBRIN DEPOLYMERIZING, FIBRINOLYTIC AGENT FOR INTRAVENOUS ADMINISTRATION | 2005 |
|
RU2286168C1 |
ANTI-THROMBOSIS, ANTI-COAGULANT, FIBRIN-DEPOLYMERIZATION, FIBRINOLYTIC AGENT FOR INTRAMUSCULAR ADMINISTRATION | 2005 |
|
RU2288737C1 |
INJECTION DOSAGE FORM FOR TREATING ACUTE ISCHEMIC STROKE AND CRANIOCEREBERAL INJURY, METHOD FOR PREPARING AND USING | 2009 |
|
RU2431496C2 |
Authors
Dates
1995-10-20—Published
1994-03-28—Filed